Found 6 matching trials
Compare the PK, Safety, and Immunogenicity of Process-Changed CMAB007 and Xolair in Healthy Adult Male Subjects
PHASE1A phase 1, randomized, double-blind, parallel group, single-dose study to c...
Location
Shanghai Xuhui Central Hospital, Shanghai
Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
PHASE3This is a multi-centre, randomized, double-blind,placebo parallel-controlle...
Location
The First Affiliated Hospital of Guangzhou Medical University
The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity
PHASE1A phase 1, randomized, double-blind, parallel group, single-dose study to c...
Location
Shanghai Xuhui Central Hospital
The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD and Safety
PHASE1A phase 1, randomized, double-blind, parallel group, single-dose study to c...
Location
Shanghai Xuhui Central Hospital
To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria
PHASE3This study is a multicenter, randomized, double-blind, positive parallel co...
Status
Active Not Recruiting
Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis
PHASE3The goal of this trial is to assess whether the efficacy of CMAB015 is simi...